In 2020, Liu et al demonstrated that miR‐592 acting as an oncogene can promote medullary thyroid cancer tumorigenesis by targeting cyclin‐dependent kinase 8 [11]. The gene discussed is CDK8; the disease is medullary thyroid gland carcinoma.